Fexofenadine-Pseudoephedrine in Allergic Rhinitis: Optimizing Relief, Safety, and Real-World Use-Dr. Samir Bhargava Aditi Dhingra31 March 2026 12:00 PM ISTIn this insightful discussion, Dr. Samir Bhargava highlights the clinical relevance of combining Fexofenadine and Pseudoephedrine combination as an...
Integrating Dapagliflozin and Sitagliptin FDC for Optimizing Outcomes in Type-2 Diabetes with Cardiometabolic-Based Chronic Disease (CMBCD) patients - Dr Kaushik Biswas Dr. Kaushik Biswas28 March 2026 10:27 AM ISTIntroduction India's T2D population carries a substantial burden-nearly two-thirds of individuals with T2D are overweight or obese, indicating a...
Expert Panel Flags Gaps in Mascot Health's Diabetes FDC Trial, Seeks Revised Phase IV Protocol Parthika Patel27 March 2026 11:12 PM ISTNew Delhi: The Central Drugs Standard Control Organisation's (CDSCO) Subject Expert Committee (SEC) on Endocrinology and Metabolism has recommended...
DTAB Sub-Panel to Reassess 29 'Irrational' FDCs Flagged by Kokate Committee: Report Susmita Roy17 Feb 2026 11:00 PM ISTNew Delhi: In a major move to strengthen drug safety and rational prescribing practices, regulators have initiated a renewed examination of 29...
Alembic Pharma Gets USFDA Final Approval for Parkinson's Drug Stalevo Generic Parthika Patel7 Feb 2026 9:19 PM ISTNew Delhi: Alembic Pharmaceuticals Limited has received final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug...
Efficacy and Safety of Dapagliflozin-Vildagliptin in Indian T2DM Patients with CV Risk Factors Dr. Bhumika Maikhuri30 Jan 2026 12:58 PM ISTThe Fixed-Dose Combination (FDC) of Dapagliflozin 5 mg + Vildagliptin 50 mg demonstrated significant improvements in Glycemic Control, Metabolic...
Fake Pharma Alert: Viral WhatsApp Image Misuses Medical Dialogues Logo To Falsely Implicate FCM Brands Nidhi Srivastava21 Jan 2026 7:33 PM ISTNew Delhi: A viral WhatsApp message featuring the Medical Dialogues logo and falsely linking several brands of Ferric Carboxymaltose to a drug alert...
Torrent Pharma Receives SEC Approval to Market Alogliptin-Metformin FDC, Asked to Conduct Phase IV Trial Susmita Roy23 Oct 2025 1:44 PM ISTNew Delhi: The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO), has granted approval to...
CDSCO Panel Rejects Pure and Cure's Empagliflozin-Based FDC, Flags Risk of UTI, Genital Mycosis Susmita Roy20 Oct 2025 5:44 PM ISTNew Delhi: Citing that there is a concern of the risk of genital mycosis and urinary tract infection (UTI) with Empagliflozin, the Subject Expert...
Exemed Pharma's Empagliflozin-Vildagliptin Combo Rejected by CDSCO Panel Over Questionable Clinical Use Susmita Roy8 Oct 2025 8:04 PM ISTNew Delhi: In a setback to Exemed Pharmaceuticals, the Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO)...
Ravenbhel Gets SEC Nod to Market Bilastine, Montelukast FDC, Phase IV Trial Mandated Susmita Roy8 Oct 2025 7:45 PM ISTNew Delhi: Waiving the requirement for bioequivalence (BE) and Phase III clinical trials, the Subject Expert Committee (SEC) functioning under the...
Sun Pharma Fails to Secure CDSCO Nod for BE, Phase III Waiver on Sitagliptin, Glimepiride, Metformin FDC Susmita Roy7 Sept 2025 3:30 PM ISTNew Delhi: Citing the absence of supporting data for the proposed strength of the fixed-dose combination (FDC) of Sitagliptin phosphate monohydrate,...
